臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

	English \| 正體中文 \| 简体中文 \| 總筆數 :0
	造訪人次 : 52880871 線上人數 : 668 教育部委託研究計畫計畫執行:國立臺灣大學圖書館

搜尋範圍

進階搜尋

登入

管理

臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

About TAIR
	About TAIR

Browse By
	Institution
	Author
	Title
	Date
	Statistics Chart
	Institution Facts
	Trend

News
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

Copyright
	Publisher & Journal Policy
	TAIR Copyright Conference Minutes

Related Links
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"hsu c"

Return to Browse by Author
Sorting by Title	Sort by Date

Showing items 346-355 of 881 (89 Page(s) Totally)
<< < 30 31 32 33 34 35 36 37 38 39 > >>
View [10|25|50] records per page

Institution	Date	Title	Author
臺大學術典藏	2021-03-09T05:18:39Z	Significant difference in the trends of female breast cancer incidence between Taiwanese and Caucasian Americans: Implications from age-period-cohort analysis	Ying-Chun Shen; Chang C.-J.; Hsu C.; Cheng C.-C.; Chiu C.-F.; Cheng A.-L.
臺大學術典藏	2021-03-09T05:18:39Z	Lack of efficacy of troglitazone at clinically achievable concentrations, with or without 9-cis retinoic acid or cytotoxic agents, for hepatocellular carcinoma cell lines	Ying-Chun Shen; Hsu C.; Chen J.-Y.; Cheng A.-L.
臺大學術典藏	2021-03-09T05:18:38Z	Molecular targeted therapy for advanced hepatocellular carcinoma	Ying-Chun Shen; Hsu C.; Cheng A.L.
臺大學術典藏	2021-03-09T05:18:38Z	Induction of Bim expression contributes to the antitumor synergy between sorafenib and mitogen-activated protein kinase/extracellular signal-regulated kinase kinase inhibitor CI-1040 in hepatocellular carcinoma	Ou D.-L.; Ying-Chun Shen; Liang J.-D.; Liou J.-Y.; Yu S.-L.; Fan H.-H.; Wang D.-S.; Lu Y.-S.; Hsu C.; Cheng A.-L.
臺大學術典藏	2021-03-09T05:18:38Z	Sorafenib for the treatment of hepatocellular carcinoma across geographic regions	Hsu C.; Ying-Chun Shen; Cheng A.L.
臺大學術典藏	2021-03-09T05:18:37Z	Phase II study of combining sorafenib with metronomic tegafur/uracil for advanced hepatocellular carcinoma	Hsu C.-H.; Ying-Chun Shen; Lin Z.-Z.; Chen P.-J.; Shao Y.-Y.; Ding Y.-H.; Hsu C.; Cheng A.-L.
臺大學術典藏	2021-03-09T05:18:37Z	Bortezomib suppresses focal adhesion kinase expression via interrupting nuclear factor-kappa B	Ko B.-S.; Chang T.-C.; Chen C.-H.; Liu C.-C.; Kuo C.-C.; Hsu C.; Ying-Chun Shen; Shen T.-L.; Golubovskaya V.M.; Chang C.-C.; Shyue S.-K.; Liou J.-Y.
臺大學術典藏	2021-03-09T05:18:37Z	Geographic difference in survival outcome for advanced hepatocellular carcinoma: Implications on future clinical trial design	Hsu C.; Ying-Chun Shen; Cheng C.-C.; Hu F.-C.; Cheng A.-L.
臺大學術典藏	2021-03-09T05:18:36Z	Early alpha-fetoprotein response predicts treatment efficacy of antiangiogenic systemic therapy in patients with advanced hepatocellular carcinoma	Shao Y.-Y.; Lin Z.-Z.; Hsu C.; Ying-Chun Shen; Hsu C.-H.; Cheng A.-L.
臺大學術典藏	2021-03-09T05:18:36Z	Adjuvant interferon therapy after curative therapy for hepatocellular carcinoma (HCC): A meta-regression approach	Ying-Chun Shen; Hsu C.; Chen L.-T.; Cheng C.-C.; Hu F.-C.; Cheng A.-L.

Showing items 346-355 of 881 (89 Page(s) Totally)
<< < 30 31 32 33 34 35 36 37 38 39 > >>
View [10|25|50] records per page